Diskussionsleiter: H. Eggebrecht (Essen), M. Kelm (Düsseldorf)
(P396) | Impact of Different Parameters of Fluid Tissue Interaction on Coronary Atherosclerosis - A Patient Specific Simulation Using Physiologic Pulsatile Flow Patterns |
|
H. Hetterich, A. Jaber, A. Curta, M. Gehring, T. Redel, V. Klauss, J. Rieber (München, Forchheim) |
(P397) | TRAF-5 prevents atherosclerosis in mice |
|
A. Missiou, P. Rudolph, N. Varo, D. Wolf, C. Münkel, S. Ernst, C. Walter, B. Sommer, C. Bode, P. Libby, A. Zirlik (Freiburg im Breisgau; Pamplona, ES; Boston, US) |
(P398) | Blockade des Interleukin‑6-Transsignalings verhindert die Entwicklung atherosklerotischer Plaques im Mausmodell |
|
H. Schütt, R. Schley, U. J. F. Tietge, G. Wätzig, D. Seegert, S. Rose-John, K. Grote, B. Schieffer (Hannover, Kiel; Groningen, NL) |
(P399) | Pharmacologic inhibition of hyaluronan synthesis by 4-methylumbelliferone aggravates atherosclerosis in apoE-deficient mice |
|
N. Nagy, T. Freudenberger, H. Jastrow, T. Suvorava, G. Kojda, A.-A. Weber, S. Ergün, J. W. Fischer (Essen, Düsseldorf) |
(P400) |
Ephrin-A1 mediated enhanced adhesion of monocytes to the endothelium involves the Rho signaling pathway. - Possible implications for atherosclerotic plaque development- |
|
S. Jellinghaus, G. Ende, D. Poitz, A. Augstein, M. Tsurkan, P. Barthel, R. Marquetant, G. Simonis, R. H. Strasser (Dresden) |
(P401) | The role of CD-4 T-Cells in the immunological pathway of arteriogenesis |
|
J. Herold, A. Francke, S. Weinert, R. H. Strasser, R. Braun-Dullaeus (Magdeburg, Dresden) |
(P402) | Targeting of Soluble Epoxide Hydrolase (sEH) reduces Atherogenesis in LDLR-deficient Mice |
|
D. Wolf, S. Ernst, C. Münkel, U. Schönbeck, C. Bode, S. Weldon, A. Zirlik (Freiburg im Breisgau; Ridgefield, US) |
(P403) | Dietary alpha-linolenic acid (ALA) diminishes atherogenesis by restricting T cell-driven inflammation |
|
S. Winnik, C. M. Matter, C. Lohmann, E. K. Richter, N. Schäfer, W.-L. Song, F. Leiber, M. R. L. Scheeder, J. Borén, G. A. FitzGerald, T. Lüscher, J. H. Beer (Zürich, Zollikofen, Baden Dättwil, CH; Philadelphia, US; Göteborg, SE) |
(P404) | High mobility group A1 protein – a new PPARgamma coregulator required for glitazone-mediated vascular protection |
|
M. Bloch, A. Prock, F. Paonessa, A. Foryst-Ludwig, K. Kappert, J. Spranger, T. Unger, A. Fusco, D. G. Sedding, A. Brunetti, U. Kintscher (Berlin, Gießen; Catanzaro, Neapel, IT) |
(P405) | Relaxin inhibits early steps in vascular inflammation |
|
A. M. Brecht, C. Bartsch, A. Westphal, G. Baumann, K. Stangl, T. Dschietzig (Berlin) |